Novo Nordisk AS 2024 AR2
The report highlights Novo Nordisk's significant growth in 2024, driven by continued innovation, capacity expansions, and strong commercial execution. The company served more than 45.2 million people living with serious chronic diseases, with global sales and operating profit both increasing by 26% at constant exchange rates. To meet unprecedented demand for its GLP-1-based medicines, Novo Nordisk invested over DKK 129 billion in scaling up manufacturing capabilities, including the acquisition of three fill-finish sites. Additionally, the company prepared its Sustainability statement in accordance with the EU Corporate Sustainability Reporting Directive (CSRD) for the first time, introducing updated roadmaps to decouple its environmental footprint from business growth.
Company: Novo Nordisk AS
Sector: Health Care
Country: Denmark
Year: 2024
Type: AR2
Pages: 152
Novo Nordisk AS
Annual Report
The report highlights Novo Nordisk's significant growth in 2024, driven by continued innovation, capacity expansions, and strong commercial execution. The company served more than 45.2 million people living with serious chronic diseases, with global sales and operating profit both increasing by 26% at constant exchange rates. To meet unprecedented demand for its GLP-1-based medicines, Novo Nordisk invested over DKK 129 billion in scaling up manufacturing capabilities, including the acquisition of three fill-finish sites. Additionally, the company prepared its Sustainability statement in accordance with the EU Corporate Sustainability Reporting Directive (CSRD) for the first time, introducing updated roadmaps to decouple its environmental footprint from business growth.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Net Zero Target
Employees